홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Water → 1-Methanesulfonyl-3,3-dimethylpiperazine

HRID 1922711
인쇄

반응식

HRID 1922711 반응식
C(OC([N:8]1[CH2:13][CH2:12][NH:11][CH2:10][C:9]1([CH3:15])[CH3:14])=O)(C)(C)C.CCN(CC)CC.[CH3:23][S:24](Cl)(=[O:26])=[O:25].O>C(Cl)Cl>[CH3:14][C:9]1([CH3:15])[NH:8][CH2:13][CH2:12][N:11]([S:24]([CH3:23])(=[O:26])=[O:25])[CH2:10]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 962WaterHCID 8471TriethylamineHCID 31297Methanesulfonyl chlorideHCID 299224001,1-Dimethylethyl 2,2-dimethyl-1-piperazinecarboxylate

생성물 1

HCID 198151421-Methanesulfonyl-3,3-dimethylpiperazine

시약·촉매·용매 1

HCID 6344Dichloromethane용매2회

실험 절차

A mixture of 2,2-dimethylpiperazine-1-carboxylic acid tert-butyl ester (1.0 g, 4.60 mmol) and NEt3 (1.3 mL, 9.34 mmol) in DCM (11 mL) was cooled to 0° C. before the drop wise addition of a solution of methanesulfonyl chloride (580 mg, 5.00 mmol) in DCM (2 mL). The resulting mixture was warmed to r.t. and allowed to stir for 30 min before H2O was added. The organic phase was dried (phase separator) and concentrated in vacuo. The resulting residue was dissolved in DCM (10 mL) and TFA (2 mL) was added. The resulting mixture was allowed to stir at r.t. for 30 min then concentrated in vacuo. The resulting residue was partitioned between DCM and sat. aq. NaHCO3 and the aqueous phase was loaded onto an Isolute® SCX-2 cartridge which was washed with H2O and MeOH. The product was eluted with 2M NH3/MeOH affording the title compound (800 mg, 90%). LCMS (method A): RT 0.29 min [M+H]+ 193.3

후처리

  1. additionwas added
  2. customThe organic phase was dried (phase separator)
  3. concentrationconcentrated in vacuo
  4. dissolutionThe resulting residue was dissolved in DCM (10 mL)
  5. additionTFA (2 mL) was added
  6. concentrationthen concentrated in vacuo
  7. customThe resulting residue was partitioned between DCM and sat. aq. NaHCO3
  8. washwas washed with H2O and MeOH
  9. washThe product was eluted with 2M NH3/MeOH affording the title compound (800 mg, 90%)
  10. customRT 0.29 min [M+H]+ 193.3

출처 및 근거

ORD 기록
ord-8d833fb5cfdb47d18c450304008084ec
출처 데이터셋
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08173650B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트